These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2964628)

  • 1. [Cancer of the prostate treated with 1 mg per day of diethylstilbestrol. Value of the determination of salivary free testosterone].
    Steg A; Laudat MH; Zerbib M; Guiban D
    Presse Med; 1988 Feb; 17(6):282. PubMed ID: 2964628
    [No Abstract]   [Full Text] [Related]  

  • 2. Gas chromatography-mass spectrometric analysis of salivary testosterone with reference to diethylstilboestrol-treated prostatic cancer patients.
    Gould VJ; Turkes AO; Gaskell SJ
    J Steroid Biochem; 1986 Feb; 24(2):563-7. PubMed ID: 3702440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Testosterone in saliva: application to the follow-up of prostate cancer].
    Navarro-Moreno MA; Rivera-Coll A
    Rev Esp Fisiol; 1990 Mar; 46(1):63-8. PubMed ID: 2204093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma testosterone in patients receiving diethylstilbestrol.
    Beck PH; McAnich JW; Goebel JL; Stutzman RE
    Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in the saliva.
    Boccon-Gibod L; Laudat MH; Guiban D; Steg A
    Prog Clin Biol Res; 1987; 243A():45-53. PubMed ID: 3659006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary testosterone in prostatic carcinoma.
    Navarro MA; Aguiló F; Villabona CM; Torrecilla C; Bonnin R
    Br J Urol; 1989 Mar; 63(3):306-8. PubMed ID: 2702429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
    Hájek J; Hanselová M; Vrubel F
    Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of diethylstilbestrol on plasma testosterone levels during 24 hours: study comparing doses of 1 and 5 mg. daily, and 1 mg. 3 times daily.
    Flores-Esteva J; Medina-Santillán R; Berea-Domínguez H; Villalpando-Casas JJ; Martínez-Romero MA; Navarrete LR; Martin-Lombard ME
    J Urol; 1980 Jun; 123(6):887-9. PubMed ID: 7382007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
    Garnick MB; Glode LM; Smith JA; Max DT
    Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.
    Pilepich MV; Buzydlowski JW; John MJ; Rubin P; McGowan DG; Marcial VA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):175-80. PubMed ID: 7721614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic cancer and its prognosis under Honvan treatment].
    Gaca A; Köhnlein HE; Köttgen H
    Med Welt; 1968 Apr; 15():961-7. PubMed ID: 5717752
    [No Abstract]   [Full Text] [Related]  

  • 13. Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.
    Garnick MB
    Urology; 1986 Jan; 27(1 Suppl):21-8. PubMed ID: 3079935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct assay for testosterone in saliva: relationship with a direct serum free testosterone assay.
    Johnson SG; Joplin GF; Burrin JM
    Clin Chim Acta; 1987 Mar; 163(3):309-18. PubMed ID: 3581474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
    Stahl F; Schnorr D; Rohde W; Dörner G
    Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen treatment in carcinoma of the prostate.
    Shearer RJ; Hendry WF; Ferguson JD
    Br Med J; 1973 Jul; 3(5870):51. PubMed ID: 4717432
    [No Abstract]   [Full Text] [Related]  

  • 17. [Salivary testosterone and its applications].
    Navarro MA; Barragán F; Villabona C; Pujol A; Bonnín MR; Rosel P
    Med Clin (Barc); 1986 Feb; 86(5):179-82. PubMed ID: 3959648
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.
    Geller J; Albert J; Yen SS; Geller S; Loza D
    J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 20. Salivary testosterone: its application in the follow-up of hypo- and hyper-androgenic states.
    Navarro MA; Villabona CM; Aguiló F; Rodriguez J
    J Clin Chem Clin Biochem; 1987 Oct; 25(10):751-2. PubMed ID: 2891782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.